![]() |
Pazopanib
- 英文名称:Pazopanib
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10566
- cas:444731-52-6
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10566 |
用途 | 科研检测 |
英文名称 | Pazopanib |
包装规格 | 1MG |
CAS编号 | 444731-52-6 |
别名 | Pazopanib |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C21H23N7O2S
分子量:437.52
溶剂:DMSO (16 mg/ml)
性状:White to off-white solid
存储:-20°C
Activity (short version):Multi-receptor tyrosine kinase inhibitor
Function / Pharmacology:Inhibits multiple receptor tyrosine kinases including VEGFR1,2 and 3 (IC50s=10, 30, 47 nM respectively) and PDGFRα, β and c-Kit (IC50s=71, 84, 74 nM respectively) and others such as FGFR.1 The drug targets both the tumor and endothelial cells in a mouse xenograft model of human multiple myeloma.2 It reduces joint pain and inhibits cartilage degeneration in rodent osteoarthritis models.3 VEGF inhibitors such as pazopanib have potential for treatment of neovascular age-related macular degeneration.4 In clinical use for renal cell carcinoma.5
分子式:C21H23N7O2S
分子量:437.52
溶剂:DMSO (16 mg/ml)
性状:White to off-white solid
存储:-20°C
Activity (short version):Multi-receptor tyrosine kinase inhibitor
Function / Pharmacology:Inhibits multiple receptor tyrosine kinases including VEGFR1,2 and 3 (IC50s=10, 30, 47 nM respectively) and PDGFRα, β and c-Kit (IC50s=71, 84, 74 nM respectively) and others such as FGFR.1 The drug targets both the tumor and endothelial cells in a mouse xenograft model of human multiple myeloma.2 It reduces joint pain and inhibits cartilage degeneration in rodent osteoarthritis models.3 VEGF inhibitors such as pazopanib have potential for treatment of neovascular age-related macular degeneration.4 In clinical use for renal cell carcinoma.5